Home Applications 213591 Application 213591
Type NDA
Sponsor NOVARTIS PHARMS CORP Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 TABRECTA CAPMATINIB HYDROCHLORIDE TABLET;ORAL 150MG Yes No 002 TABRECTA CAPMATINIB HYDROCHLORIDE TABLET;ORAL 200MG Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N213591-001 TABRECTA CAPMATINIB HYDROCHLORIDE EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 N213591-002 TABRECTA CAPMATINIB HYDROCHLORIDE EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06
Orange Book patents# Current patent rows page 1 of 1 · 14 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N213591-001 12084449 2027-11-19 U-2813 2024-10-02 N213591-001 8461330 2027-11-19 Drug substance, Drug product 2020-05-26 N213591-001 8901123 2029-05-20 U-2813 2020-05-26 N213591-001 8420645 2031-06-05 Drug substance, Drug product 2020-05-26 N213591-001 7767675 2032-11-19 Drug substance, Drug product 2020-05-26 N213591-001 10596178 2035-07-22 Drug product 2020-06-26 N213591-001 12208101 2035-07-22 Drug product 2025-02-03 N213591-002 12084449 2027-11-19 U-2813 2024-10-02 N213591-002 8461330 2027-11-19 Drug substance, Drug product 2020-05-26 N213591-002 8901123 2029-05-20 U-2813 2020-05-26 N213591-002 8420645 2031-06-05 Drug substance, Drug product 2020-05-26 N213591-002 7767675 2032-11-19 Drug substance, Drug product 2020-05-26 N213591-002 10596178 2035-07-22 Drug product 2020-06-26 N213591-002 12208101 2035-07-22 Drug product 2025-02-03
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N213591-001 ODE-291 2027-05-06 N213591-002 ODE-291 2027-05-06
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 74 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N213591-001 TABRECTA EQ 150MG BASE TABLET / ORAL RLD 2020-05-06 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N213591-002 TABRECTA EQ 200MG BASE TABLET / ORAL RLD, RS 2020-05-06 87673890dc5c…
Observed Orange Book patent history# Patent history page 1 of 11 · 402 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N213591-001 12084449 2027-11-19 U-2813 2024-10-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213591-001 8461330 2027-11-19 Drug substance, Drug product 2020-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213591-001 8901123 2029-05-20 U-2813 2020-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213591-001 8420645 2031-06-05 Drug substance, Drug product 2020-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213591-001 7767675 2032-11-19 Drug substance, Drug product 2020-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213591-001 10596178 2035-07-22 Drug product 2020-06-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213591-001 12208101 2035-07-22 Drug product 2025-02-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213591-002 12084449 2027-11-19 U-2813 2024-10-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213591-002 8461330 2027-11-19 Drug substance, Drug product 2020-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213591-002 8901123 2029-05-20 U-2813 2020-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213591-002 8420645 2031-06-05 Drug substance, Drug product 2020-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213591-002 7767675 2032-11-19 Drug substance, Drug product 2020-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213591-002 10596178 2035-07-22 Drug product 2020-06-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213591-002 12208101 2035-07-22 Drug product 2025-02-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-001 12084449 2027-11-19 U-2813 2024-10-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-001 8461330 2027-11-19 Drug substance, Drug product 2020-05-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-001 8901123 2029-05-20 U-2813 2020-05-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-001 8420645 2031-06-05 Drug substance, Drug product 2020-05-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-001 7767675 2032-11-19 Drug substance, Drug product 2020-05-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-001 10596178 2035-07-22 Drug product 2020-06-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-001 12208101 2035-07-22 Drug product 2025-02-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-002 12084449 2027-11-19 U-2813 2024-10-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-002 8461330 2027-11-19 Drug substance, Drug product 2020-05-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-002 8901123 2029-05-20 U-2813 2020-05-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-002 8420645 2031-06-05 Drug substance, Drug product 2020-05-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-002 7767675 2032-11-19 Drug substance, Drug product 2020-05-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-002 10596178 2035-07-22 Drug product 2020-06-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213591-002 12208101 2035-07-22 Drug product 2025-02-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N213591-001 12084449 2027-11-19 U-2813 2024-10-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213591-001 8461330 2027-11-19 Drug substance, Drug product 2020-05-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213591-001 8901123 2029-05-20 U-2813 2020-05-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213591-001 8420645 2031-06-05 Drug substance, Drug product 2020-05-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213591-001 7767675 2032-11-19 Drug substance, Drug product 2020-05-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213591-001 10596178 2035-07-22 Drug product 2020-06-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213591-001 12208101 2035-07-22 Drug product 2025-02-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213591-002 12084449 2027-11-19 U-2813 2024-10-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213591-002 8461330 2027-11-19 Drug substance, Drug product 2020-05-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213591-002 8901123 2029-05-20 U-2813 2020-05-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213591-002 8420645 2031-06-05 Drug substance, Drug product 2020-05-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213591-002 7767675 2032-11-19 Drug substance, Drug product 2020-05-26 6a471c1ec25d…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 4 · 144 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 8 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0078-0709 TABRECTA capmatinib Novartis Pharmaceuticals Corporation NDA Current 0078-0709 TABRECTA capmatinib Novartis Pharmaceuticals Corporation NDA Current 0078-0709 TABRECTA capmatinib Novartis Pharmaceuticals Corporation NDA Current 0078-0709 TABRECTA capmatinib Novartis Pharmaceuticals Corporation NDA Current 0078-0716 TABRECTA capmatinib Novartis Pharmaceuticals Corporation NDA Current 0078-0716 TABRECTA capmatinib Novartis Pharmaceuticals Corporation NDA Current 0078-0716 TABRECTA capmatinib Novartis Pharmaceuticals Corporation NDA Current 0078-0716 TABRECTA capmatinib Novartis Pharmaceuticals Corporation NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 77892 SUPPL 2024-03-21 77847 SUPPL 2024-03-15 73884 SUPPL 2023-03-27 73872 SUPPL 2023-03-27 71789 SUPPL 2022-08-11 71769 SUPPL 2022-08-11 69968 SUPPL 2022-01-25 69959 SUPPL 2022-01-25 63374 ORIG 2020-06-01 62845 ORIG 2020-05-07 62842 ORIG 2020-05-06